The aim of this review is to summarize present evidence of an association between
circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether …

C-reactive protein (CRP) is the prototypical acute phase serum protein, rising rapidly in
response to inflammation. CRP binds to phosphocholine (PC) and related molecules on …

Observational epidemiological studies suffer from many potential biases, from confounding
and from reverse causation, and this limits their ability to robustly identify causal …

Background Elevated levels of C-reactive protein (CRP) are associated with increased risks
of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is …

Objective: Using reciprocal Mendelian randomization, we aim to assess the direction of
causality in relationships between BMI and CRP and to demonstrate this as a promising …

C-reactive protein (CRP) is well-known as a sensitive albeit unspecific biomarker of
inflammation. In most rheumatic conditions, the level of this evolutionarily highly conserved …

C-reactive protein is postulated to embody an index that can reflect cardiovascular risk and
can be used to independently predict major cardiovascular events and mortality. On the …

C-reactive protein (CRP) has been shown to be associated with type 2 diabetes, but whether
CRP has a causal role is not yet clear. We examined the association in the Rotterdam Study …

Measurement of serum C-reactive protein (CRP) level is in widespread clinical use as a
sensitive marker of inflammation. CRP has a role in the clearance of bacteria and of dying …

C-reactive protein (CRP), a blood marker of inflammation and a hallmark of the acute-phase
response, has been shown to be a powerful and specific predictor of cardiovascular event …